KANG Wei
机构: The Chinese University of Hong Kong
每年引用次数
引用次数
引用: 8,737
H-指数: 49
I10-指数 : 99
出版物: 173
NOTCH3, a crucial target of miR-491-5p/miR-875-5p, promotes gastric carcinogenesis by upregulating PHLDB2 expression and activating Akt pathway
Kwok Wai Lo , Alfred S L Cheng , Ka Fai To , Yujuan Dong
Oncogene 40 ( 9) 1578 -1594
16
2021
LIMK1 promotes peritoneal metastasis of gastric cancer and is a therapeutic target.
Philip Wai Yan Chiu , Ka Fai To , Jingyu Deng , Wei Kang
Oncogene 40 ( 19) 3422 -3433
20
2021
267 PCSK9 IS A THERAPEUTIC TARGET IN KRAS-MUTANT COLORECTAL CANCER
Chi Chun Wong , Jianlin Wu , Lam-Shing Chan , Fenfen Ji
Gastroenterology 160 ( 6)
2021
124 RNA N6-METHYLADENOSINE DEMETHYLASE ALKBH5 DRIVES IMMUNE SUPPRESSION TO PROMOTE COLORECTAL TUMORIGENESIS BY TARGETING AXIN2-WNT/DKK1 AXIS
Jianning Zhai , Huarong Chen , Chi Chun Wong , Shiyan Wang
Gastroenterology 160 ( 6)
2021
Zinc-finger protein 545 is a novel tumour suppressor that acts by inhibiting ribosomal RNA transcription in gastric cancer
Shiyan Wang , Yingduan Cheng , Wan Du , Leina Lu
Gut 62 ( 6) 833 -841
68
2013
Sa1692 Characterization of the Helicobacter pylori-Induced STAT3 Activation and the Associated Signaling Network in Gastric Cancer
Junhong Zhao , Wei Kang , Yu Juan Dong , Minnie Y Go
Gastroenterology 144 ( 5)
2013
Tu1289 SCNN1B Is a Novel Tumor Suppressor Gene Through Inducing Ubiquitin-Mediated Degradation of GRP78 and Is a Potential Prognostic Biomarker in GC
Yun Qian , Chi Chun Wong , Wei Kang , Jianmin Si
Gastroenterology 150 ( 4)
2016
Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming
Lei Xiong , Feng Wu , Qiong Wu , Liangliang Xu
Nature Communications 10 ( 1) 335
27
2019
Dapper Homolog 1 Is a Novel Tumor Suppressor in Gastric Cancer through Inhibiting the Nuclear Factor-κB Signaling Pathway
Shiyan Wang , Wei Kang , Minnie YY Go , Joanna HM Tong
Molecular Medicine 18 ( 10) 1402 -1411
23
2012
MCM family in gastrointestinal cancer and other malignancies: From functional characterization to clinical implication.
Yifei Wang , Huarong Chen , Jinglin Zhang , Alfred SL Cheng
Biochimica et Biophysica Acta 1874 ( 2) 188415
3
2020
Stathmin1 Plays Oncogenic Role and Is a Target of MicroRNA-223 in Gastric Cancer
Wei Kang , Joanna HM Tong , Anthony WH Chan , Raymond WM Lung
PLoS ONE 7 ( 3) e33919
68
2012
The emerging role of Slit-Robo pathway in gastric and other gastro intestinal cancers
Tingting Huang , Wei Kang , Alfred SL Cheng , Jun Yu
BMC Cancer 15 ( 1) 950 -950
24
2015
PKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53.
Li Zhang , Weilin Li , Lei Cao , Jiaying Xu
Oncogene 38 ( 23) 4590 -4604
27
2019
FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential.
Jinglin Zhang , Chi Chun Wong , Kam Tong Leung , Feng Wu
Oncogene 39 ( 43) 6647 -6663
22
2020
Gastric cancer: genome damaged by bugs.
Yanan Zhao , Jinglin Zhang , Alfred SL Cheng , Jun Yu
Oncogene 39 ( 17) 3427 -3442
9
2020
AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis
Yuhang Zhou , Jinglin Zhang , Hui Li , Tingting Huang
Oncogene 39 ( 22) 4375 -4389
23
2020
Elevated PRC1 in gastric carcinoma exerts oncogenic function and is targeted by piperlongumine in a p53-dependent manner
Bin Zhang , Xiaoting Shi , Guifang Xu , Wei Kang
Journal of Cellular and Molecular Medicine 21 ( 7) 1329 -1341
20
2017
The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma.
Jinglin Zhang , Tingting Huang , Yuhang Zhou , Alfred SL Cheng
Journal of Cellular and Molecular Medicine 22 ( 1) 38 -45
19
2018
Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic features.
Xiangchun Li , Weiqi Xu , Wei Kang , Sunny H Wong
Theranostics 8 ( 6) 1740 -1751
69
2018
VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6.
Yujuan Dong , Yanquan Zhang , Wei Kang , Guoping Wang
Theranostics 9 ( 22) 6517 -6531
21
2019